Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin - PubMed (original) (raw)
. 1997 Jul 11;46(27):626-8, 635.
- PMID: 9218649
Free article
Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997.
Free article
Abstract
Staphylococci are one of the most common causes of community- and hospital-acquired infection. In many U.S. hospitals, strains of staphylococci (i.e., Staphylococcus aureus or coagulase-negative staphylococci) are resistant to all available antimicrobials except vancomycin. Rare cases of infection in the United States (1) have been caused by coagulase-negative staphylococci with reduced susceptibility to vancomycin (minimum inhibitory concentration [MIC] > or = 8 microg/mL)(2).
Similar articles
- Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997 Aug 22;46(33):765-6. MMWR Morb Mortal Wkly Rep. 1997. PMID: 9272582 - Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997 Sep 5;46(35):813-5. MMWR Morb Mortal Wkly Rep. 1997. PMID: 9310213 - Follow these guidelines for resistant S. aureus.
[No authors listed] [No authors listed] Healthc Benchmarks. 1997 Nov;4(11):164-5. Healthc Benchmarks. 1997. PMID: 10175782 No abstract available. - Update on emerging infections: news from the Centers for Disease Control and Prevention.
Moran GJ, Mount J. Moran GJ, et al. Ann Emerg Med. 2003 Jan;41(1):148-51. doi: 10.1067/mem.2003.26. Ann Emerg Med. 2003. PMID: 12514697 Review. No abstract available. - The role of vancomycin in the treatment paradigm.
Stevens DL. Stevens DL. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S51-7. doi: 10.1086/491714. Clin Infect Dis. 2006. PMID: 16323121 Review.
Cited by
- Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.
Spagnolo AM, Orlando P, Panatto D, Amicizia D, Perdelli F, Cristina ML. Spagnolo AM, et al. J Prev Med Hyg. 2014 Dec;55(4):137-44. J Prev Med Hyg. 2014. PMID: 26137787 Free PMC article. Review. - Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon.
Périchon B, Courvalin P. Périchon B, et al. Antimicrob Agents Chemother. 2006 Nov;50(11):3622-30. doi: 10.1128/AAC.00410-06. Epub 2006 Sep 5. Antimicrob Agents Chemother. 2006. PMID: 16954318 Free PMC article. - Relationships between enterococcal virulence and antimicrobial resistance.
Mundy LM, Sahm DF, Gilmore M. Mundy LM, et al. Clin Microbiol Rev. 2000 Oct;13(4):513-22. doi: 10.1128/CMR.13.4.513. Clin Microbiol Rev. 2000. PMID: 11023953 Free PMC article. Review. - Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus.
Périchon B, Courvalin P. Périchon B, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4281-5. doi: 10.1128/AAC.48.11.4281-4285.2004. Antimicrob Agents Chemother. 2004. PMID: 15504853 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical